Home / Oxaliplatin / United States
US ATC L01XA03 · updated 2 Nov 2026
Oxaliplatin shortage in United States
Is there an Oxaliplatin shortage in United States?
Yes. As of 2 Nov 2026, 4 Oxaliplatin products are reported short in United States, the first since 25 Feb 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Germany, Italy, Spain, Ireland, Austria, Belgium, Czechia, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10) discontinuation | Fresenius Kabi USA, LLC | 25 Feb 2026 | not given | Not stated |
| US | Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20) discontinuation | Fresenius Kabi USA, LLC | 25 Feb 2026 | not given | Not stated |
| US | Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10) discontinuation | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 29 Jun 2026 | not given | Not stated |
| US | Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20) discontinuation | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 29 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).